Finzati - Logo
HYFT logo

MindWalk Holdings Corp.

HYFTBiotechnology
$1.32
-0.01 (-0.75%)
Current price
EarningsLatest report: Apr 30, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$63.43M
Growth
7.3%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.3Healthy liquidity · 2.8Negative growth trendWeak profitability
Financial data as of: Apr 30, 2026, 12:00 AM UTCLast earnings update: Apr 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$1.32
Change-0.75%
Market Cap$63.43M
52W Range0.99 - 3.25
Beta0.84
Gross Margin58.80%
Oper. Margin-96.01%
Profit Margin-89.66%
Debt/Eq0.30
Current Ratio2.80
Quick Ratio2.72
Revenue 5Y7.29%

Investment DNA

How strong this company looks for long-term investors

35
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
56/100
Why this score
Manageable debt level · 0.3Healthy liquidity · 2.8Negative growth trendWeak profitability

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-05
Low
$5.00
Mean
$5.00
Median
$5.00
High
$5.00

Company Overview

IPO: 1/7/2002
Industry: Biotechnology
P/B i: 6.39
Debt / Equity i: 0.30
Operating Margin: -96.01%
Net Margin: -89.66%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.30
Current Ratio: 2.80
Quick Ratio: 2.72
Status: Good

Insider Transactions

Recent executive and insider activity

3 high-volume insider sells detected
Aisling Capital II LP
Transaction: 12/12/2008
SELL
Change
-10,000
Price
Not reported
Filing
03/03/2008
Type
SELL
Aisling Capital II LP
Transaction: 12/12/2008
SELL
Change
-1
Price
Not reported
Filing
03/03/2008
Type
SELL
Aisling Capital II LP
Transaction: 12/12/2008
BUY
Change
+10,412
Price
Not reported
Filing
03/03/2008
Type
BUY